2016 Annual Meeting | Precision Neurology: The Promise and Perils of Whole Exome Sequencing for Neurological Disorders
| 01:00 PM - 01:05 PM |
Introduction
Amy R. Brooks-Kayal, MD, FAAN |
|
| 01:05 PM - 01:30 PM |
Whole Exome/Genome Sequencing: What Is It? When To Get It? What To Do With the Information When You Have It?
|
|
| 01:30 PM - 01:55 PM |
Genetics and the Dawn of Precision Medicine in Epilepsy
Daniel H. Lowenstein, MD |
|
| 01:55 PM - 02:15 PM |
Alzheimer's Disease Sequencing Project
Richard P. Mayeux, MD, MSc, FAAN |
|
| 02:15 PM - 02:40 PM |
Gene Function: Does Your Patient's Gene Mutation Cause Disease and How?
Jack M. Parent, MD |
|
| 02:40 PM - 03:00 PM |
Personalized Neurology from a Patient Perspective
Tracy Dixon-Salazar, PhD |
| Daniel H. Lowenstein, MD | Dr. Lowenstein has received research support from NIH. |
| Richard P. Mayeux, MD, MSc, FAAN | Dr. Mayeux has nothing to disclose. |
| Jack M. Parent, MD | No disclosure on file |
| Amy R. Brooks-Kayal, MD, FAAN | Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Brooks-Kayal has stock in Johnson and Johnson. The institution of Dr. Brooks-Kayal has received research support from NINDS. |
| Tracy Dixon-Salazar, PhD | Dr. Dixon-Salazar has received personal compensation for serving as an employee of Lennox-Gastaut Syndrome (LGS) Foundation. Dr. Dixon-Salazar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuelis. |
| No disclosure on file |